May well: On Could 30, FDA introduced an innovation obstacle to spur advancement of healthcare devices ‒ which includes electronic overall health and diagnostics ‒ that focus on soreness, addiction and diversion.Along with the delayed-release procedure, executives theorized, the drug would f